Reata Pharmaceuticals Inc

NORTHERN TRUST CORP

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

287,968

Value ($000)

29,361

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	29,361	0.0%	287,968	6/30/2023
2023 Q1	5/15/2023	25,717	0.0%	282,848	3/31/2023
2022 Q4	2/13/2023	10,329	0.0%	271,891	12/31/2022
2022 Q3	11/14/2022	6,493	0.0%	258,393	9/30/2022
2022 Q2	8/12/2022	7,928	0.0%	260,905	6/30/2022
2022 Q1	5/13/2022	8,798	0.0%	268,555	3/31/2022
2021 Q4	2/8/2022	7,282	0.0%	276,180	12/31/2021
2021 Q3	11/15/2021	27,801	0.0%	276,328	9/30/2021
2021 Q2	8/13/2021	40,917	0.0%	289,096	6/30/2021
2021 Q1	5/12/2021	13,143	0.0%	131,819	3/31/2021
2020 Q4	2/11/2021	15,475	0.0%	125,180	12/31/2020
2020 Q3	11/16/2020	11,735	0.0%	120,462	9/30/2020
2020 Q2	8/14/2020	20,263	0.0%	129,874	6/30/2020
2020 Q1	5/14/2020	41,407	0.0%	286,874	3/31/2020
2019 Q4	2/14/2020	57,311	0.0%	280,346	12/31/2019